MFAP2 expression was also correlated with chemokine receptors in gliomas, such as CCR3, CCR7, CXCR4, and CXCR6, which were significantly associated with MFAP2 expression in both LGG and GBM (Figure 5). This evidence concerns the gene MFAP2 and central nervous system cancer.